ClinicalTrials.Veeva

Menu

A One Year Trial Evaluating the Safety and Efficacy of the ALK House Dust Mite Allergy Tablet (MT-06)

A

ALK-Abelló

Status and phase

Completed
Phase 3

Conditions

House Dust Mite Allergy

Treatments

Biological: AIT Tablet

Study type

Interventional

Funder types

Industry

Identifiers

NCT01454544
2011-002277-38 (EudraCT Number)
MT-06

Details and patient eligibility

About

The primary aim of this trial is to evaluate the efficacy of the ALK house dust mite tablet given once daily compared to a placebo tablet in the treatment of house dut mite allergic rhinits.

Additionally the secondary objective of the trial is to evaluate the safety and tolarability of the ALK house dust mite tablet.

Immunotherapy has been shown to provide therapeutic benefits to subjects with house dust mite induced allergy. This trial is planned to investigate if clinically relevant improvements in rhinitis symptoms and with less use of symptomatic medication can be obtained in subjects with a history of poor didease control despite of use of symptomatic medications.

Enrollment

992 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • A history of house dust mite allergy
  • Use of symptomatice medication for treatment of house dust mite allergy
  • Positive skin prick test to mites
  • Positive specific IgE

Exclusion criteria

  • History of uncontrolled asthma
  • Overlapping symptomatice allergies
  • Previous treatment with immunotherapy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

992 participants in 3 patient groups, including a placebo group

ALK house dust mite tablet 6 DU
Experimental group
Treatment:
Biological: AIT Tablet
ALK house dust mite tablet 12 DU
Experimental group
Treatment:
Biological: AIT Tablet
Placebo
Placebo Comparator group
Treatment:
Biological: AIT Tablet

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems